None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The eligible participants were over 18 years of age and had type 2 diabetes for more than one year. Their baseline glycated hemoglobin (HbA1c) levels were between 7.0 and 10.0%.
Exclusion criteria
Exclusion criteria: Participants with any significant medical diseases were excluded. Those with creatinine levels higher than 1.5 or 1.4 mg/dL for men or women, respectively, or aspartate aminotransferase (AST) or alanine aminotransferase (ALT) levels more than 2.5 times the upper normal limit, were also excluded. We excluded participants who had not been taking stable diabetes medications for the three months before enrollment. Insulin pump users were not included in this study. Participants of other clinical trials or plans were also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| fasting glucose ;systolic blood pressure ;diastolic blood pressure ;body weight;waist circumference;Total cholesterol;Triglyceride;HDL-cholesterol;LDL-cholesterol;MMS: Modified Morisky Scale;PACIC: Patient Assessment of Chronic Illness Care;DTSQs and DTSQc, Diabetes Treatment Satisfaction Questionnaire s tatus and change version;Satisfaction after smartphone-based monitoring service ;adverse events | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital